Longitudinal PET/CT-Derived Body Composition Changes During Systemic Therapy in Patients with Lung Cancer
Purpose: Host metabolic status may affect outcomes in lung cancer, but longitudinal changes in body composition and systemic metabolism remain incompletely understood. We examined whether paired 18F-FDG PET/CT-derived host features were associated with progression-free survival (PFS) during systemic therapy. Methods: F...